Treatment · CellularCompounded

NAD+ Injection

A coenzyme central to cellular energy, explored to support energy and recovery in midlife.

  • Cellular energy metabolism (explored)
  • Energy and recovery in midlife (explored)
  • Direct delivery without clinic time
Per month$199

Indicative price · confirmed after eligibility · prescription treatment

Cellular Treatment
Cellular
What it is

What NAD+ actually does

NAD+ is the most-discussed molecule in longevity, and one of the most oversold. Both of those are worth taking seriously.

The underlying biology is real and well characterized: NAD+ is genuinely essential to how your cells make energy, and it genuinely declines with age. What is far less settled is whether topping it up produces the effects people hope for.

NAD+ — nicotinamide adenine dinucleotide — is a coenzyme present in every cell you have. It is not a supplement your body optionally uses; it is a component of the machinery that converts food into usable energy.

It has two main jobs. It shuttles electrons through the reactions that produce cellular energy, and it is consumed by repair and regulatory enzymes involved in DNA maintenance and cellular housekeeping.

That second job is why it draws longevity interest: those repair processes use NAD+ up, and demand on them does not fall with age. Meanwhile measured NAD+ levels decline. The hypothesis follows naturally — that some of what we experience as aging reflects cells running the same machinery with less of a critical input.

It is a good hypothesis. It is not yet a demonstrated treatment, and the gap between those is where most NAD+ marketing operates.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy production that declines with age. The injectable form is explored to support energy and cellular health for eligible patients.

Our model

How it works here

Every plan follows one path. Each step feeds the next. See the NAD+ Therapy approach.

  1. 01

    Measure

    We baseline your labs, history, and goals.

  2. 02

    Plan

    A clinician decides whether this fits — and what else might serve you.

  3. 03

    Act

    If appropriate, you start with clear guidance and high-touch support.

  4. 04

    Track

    We monitor how you respond on a defined cadence.

  5. 05

    Adjust

    Protocols are refined over time. Guided care, not a kit in the mail.

Injection, IV, or oral precursors?

This is the decision most people arrive with, and the honest comparison matters more than the sales pitch.

InjectionIV infusion ○Oral precursors (NMN / NR) ○
Available at ACT 2YesNoNo
What you receiveNAD+ directlyNAD+ directlyA precursor your body converts
Bypasses digestionYesYesNo
SettingAt home, self-administeredClinic or mobile service, seated for the sessionAt home
Time costMinimalSubstantial — a session takes hoursMinimal
Relative cost per exposureMiddleHighestLowest
Common experienceInjection-site reactionsFlushing, chest tightness or nausea if run quicklyGenerally well tolerated
Evidence qualityEarlyEarlyEarly, and precursor conversion varies
Best suited toPeople who want direct delivery without clinic timePeople who prefer a supervised clinical settingPeople wanting the lowest-cost, lowest-commitment entry

Scroll the table sideways to compare →

Options marked ○ are not part of our catalog. They are included so the comparison is complete rather than flattering.

The honest summary: injection and IV both deliver NAD+ directly — the difference is mostly time, cost and setting rather than a difference in what reaches you. IV is not more effective by virtue of being an infusion; it is more supervised, slower and more expensive. If clinic time is the obstacle, injection is the practical route, and that is the one we offer.

Oral precursors are the cheapest entry point and the furthest from direct — your body has to convert them, and how efficiently varies.

Where the evidence actually stands

What is well established: NAD+ is essential to cellular energy metabolism, and levels decline with age. That part is not controversial.

What is not: that raising NAD+ through supplementation or injection reverses that decline in a way you would notice, or produces durable benefits to energy, cognition or healthspan. The human trials are small, short and mostly focused on whether levels rise — not on whether people feel or function better.

What we would say plainly: if NAD+ is tried, it should come with a defined checkpoint where you and a clinician assess honestly whether anything changed. Response varies a lot, some people report a clear difference and others notice nothing, and there is currently no reliable way to predict which you will be. A provider unwilling to reach the conclusion “this is not doing anything for you” is not running a therapy — they are running a subscription.

What to expect

Injection-site reactions — redness, tenderness — are the most commonly reported effect and are generally minor.

Some people describe a flushing sensation or mild nausea, more commonly when NAD+ is given rapidly, which is one of the practical arguments for a measured approach rather than a fast infusion.

Response builds rather than arriving, and honest expectation-setting matters here more than with most things we offer.

It is not appropriate during pregnancy or breastfeeding, and anyone with significant kidney or liver impairment or a complex medication list needs proper review first.

How it's delivered

Delivery

An injection, considered and guided by a clinician for eligible patients.

Who it's for

Who this suits, and what it is not

Adults focused on energy and healthspan who have already handled the foundations — sleep, training, nutrition, and any hormonal or metabolic issue driving how they feel — and who will engage with an honest checkpoint about whether it is working. See the NAD+ therapy approach.

It is a poor first move

If fatigue is your complaint, the productive first questions are thyroid function, iron status, vitamin D, sleep quality, blood sugar and hormones. Those have clearer answers and better evidence, and lab testing is how you find them. Reaching for NAD+ before checking those is how people spend money on a maybe while a treatable cause goes unaddressed.

If oxidative stress is part of your picture, glutathione is often discussed alongside it. If mitochondrial support specifically is the interest, methylene blue is the other conversation — though it is ruled out for anyone on an antidepressant. And if you have not established a baseline yet, start there.

Further reading: NAD+ explained and peptides and longevity.

Low noise. High signal.

An honest word on the evidence

NAD+ is popular in longevity circles, but robust long-term human evidence for many of the claimed benefits is still limited. We keep it clinician-led with realistic expectations, which in practice means a defined point at which we ask whether it is doing anything for you — and a genuine willingness to answer no. Results vary.

References

Government and professional-society sources consulted for this page.

  1. Dietary and Herbal SupplementsNIH National Center for Complementary and Integrative Health
  2. Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration

How we write and review our content

Questions

Frequently asked questions

  • It is a coenzyme central to cellular energy production that declines with age. It is present in every cell and is essential to converting food into usable energy, as well as to DNA repair and cellular maintenance processes. The therapy is explored to support energy.

  • Both deliver NAD+ directly and bypass digestion. The practical differences are time, cost and setting rather than what reaches you — an IV session takes hours and typically costs more. We offer the injection because for most people it is the more workable route.

  • Those are precursors your body has to convert into NAD+, and conversion efficiency varies between people. Injection delivers NAD+ directly. Precursors are cheaper and lower-commitment; direct delivery is more certain about what reaches you.

  • Interest is high, but robust long-term human data is limited. What is established is that NAD+ is essential to cellular energy and declines with age. What is not established is that raising it produces durable, noticeable benefits. We set realistic expectations and build in a checkpoint.

  • Response builds rather than arriving, and it varies considerably — some people report a clear difference, others notice nothing. That is why a defined review point is part of the plan, including a genuine willingness to stop.

  • Injection-site reactions are the most common and are usually minor. Some people describe flushing or mild nausea, more often when NAD+ is given rapidly.

  • Fix your sleep first. NAD+ cannot outrun a sleep debt, an untreated thyroid problem or low iron — and those are far more likely to explain midlife fatigue. That is what measuring first is for.

  • Often, yes. Glutathione and B12 are commonly discussed alongside it, and NAD+ frequently sits within a broader plan rather than standing alone. Your clinician reviews the combination.

  • No. It is a compounded medication prepared by a licensed compounding pharmacy under a prescription written for you, and any use for energy or healthspan is off-label.

Own your next chapter

See if NAD+ Injection fits your plan

The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.

We measure first. Then we act.

ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.